These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19346116)

  • 21. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of four methods for assessing in vivo beta-cell function in normal, obese and non-insulin-dependent diabetic man.
    Davis SN; Piatti PM; Monti L; Möller N; Ng LL; Coppack S; Antsiferov M; Brown MD; Alberti KG
    Diabetes Res; 1992 Mar; 19(3):107-17. PubMed ID: 1286545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.
    Sesti G; Sciacqua A; Cardellini M; Marini MA; Maio R; Vatrano M; Succurro E; Lauro R; Federici M; Perticone F
    Diabetes Care; 2005 Jan; 28(1):120-5. PubMed ID: 15616244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin sensitivity, and β-cell function in relation to hemoglobin A1C.
    Marini MA; Frontoni S; Succurro E; Arturi F; Sciacqua A; Hribal ML; Perticone F; Sesti G
    Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):27-33. PubMed ID: 23601331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low plasma insulin-like growth factor-1 concentrations predict worsening of insulin-mediated glucose uptake in older people.
    Paolisso G; Tagliamonte MR; Rizzo MR; Carella C; Gambardella A; Barbieri M; Varricchio M
    J Am Geriatr Soc; 1999 Nov; 47(11):1312-8. PubMed ID: 10573439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.
    Chen X; Maldonado E; DeFronzo RA; Tripathy D
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1398-1409. PubMed ID: 33524152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study.
    Runchey SS; Pollak MN; Valsta LM; Coronado GD; Schwarz Y; Breymeyer KL; Wang C; Wang CY; Lampe JW; Neuhouser ML
    Eur J Clin Nutr; 2012 Oct; 66(10):1146-52. PubMed ID: 22892437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma free fatty acids do not provide the link between obesity and insulin resistance or β-cell dysfunction: results of the Reading, Imperial, Surrey, Cambridge, Kings (RISCK) study.
    Johns I; Goff L; Bluck LJ; Griffin BA; Jebb SA; Lovegrove JA; Sanders TA; Frost G; Dornhorst A
    Diabet Med; 2014 Nov; 31(11):1310-5. PubMed ID: 25047698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ageing related changes of insulin secretion and insulin sensitivity among normal glucose tolerance individuals in China].
    Zhu HQ; Yang ZJ; Zhang B; Xiao JZ; Yang WY
    Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(28):1948-53. PubMed ID: 22944266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth.
    Burns SF; Bacha F; Lee SJ; Tfayli H; Gungor N; Arslanian SA
    Diabetes Care; 2011 Sep; 34(9):2033-40. PubMed ID: 21750275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels.
    Marini MA; Succurro E; Frontoni S; Mastroianni S; Arturi F; Sciacqua A; Lauro R; Hribal ML; Perticone F; Sesti G
    Diabetes Care; 2012 Apr; 35(4):868-72. PubMed ID: 22357182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion.
    Müssig K; Staiger H; Machicao F; Kirchhoff K; Guthoff M; Schäfer SA; Kantartzis K; Silbernagel G; Stefan N; Holst JJ; Gallwitz B; Häring HU; Fritsche A
    Diabetes; 2009 Jul; 58(7):1715-20. PubMed ID: 19366866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
    Kim JY; Michaliszyn SF; Nasr A; Lee S; Tfayli H; Hannon T; Hughan KS; Bacha F; Arslanian S
    Diabetes Care; 2016 Aug; 39(8):1431-9. PubMed ID: 27293201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.
    Perseghin G; Ghosh S; Gerow K; Shulman GI
    Diabetes; 1997 Jun; 46(6):1001-9. PubMed ID: 9166672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.
    Liang S; Hu Y; Liu C; Qi J; Li G
    Lipids Health Dis; 2016 Jun; 15():112. PubMed ID: 27343122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents.
    Tricò D; Natali A; Arslanian S; Mari A; Ferrannini E
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus.
    Brøns C; Spohr C; Storgaard H; Dyerberg J; Vaag A
    Eur J Clin Nutr; 2004 Sep; 58(9):1239-47. PubMed ID: 15054439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.